Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma - Quiz - MDSpire

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

  • By

  • Ming Yao

  • Xavier Cheng-Hong Tsai

  • Chung-Wu Lin

  • Shu-Lang Liao

  • Cheng-Ping Wang

  • Wei-Li Ma

  • Yi-Hsuan Wei

  • Hsiao-Wei Lee

  • Jyh-Ming Liou

  • Wei-Li Chen

  • I-Jong Wang

  • Ann-Lii Cheng

  • Sung-Hsin Kuo

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

  • by Ming Yao, Xavier Cheng-Hong Tsai, Chung-Wu Lin, Shu-Lang Liao, Cheng-Ping Wang, Wei-Li Ma, Yi-Hsuan Wei, Hsiao-Wei Lee, Jyh-Ming Liou, Wei-Li Chen, I-Jong Wang, Ann-Lii Cheng, Sung-Hsin Kuo

  • May 29, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report